Document is current
Any future updates will be listed below
-
Authors
Bouillon, Roger https://orcid.org/0000-0002-6446-3763
Manousaki, Despoina
Rosen, Cliff https://orcid.org/0000-0003-3436-8199
Trajanoska, Katerina
Rivadeneira, Fernando https://orcid.org/0000-0001-9435-9441
Richards, J. Brent
- License Information
-
More Information
Article History
Accepted: 25 October 2021
First Online: 23 November 2021
Competing interests
: R.B. received modest speaking or consultancy fees from Fresenius, Abiogen, FAES Farma, Ceres and Proctor and Gamble. J.B.R. has worked as a consultant to GlaxoSmithKline and Deerfield Capital. The other authors declare no competing interests
Free to read: This content has been made available to all.
